Clinical Trials Finder
Independent ClinicalTrials.gov directory
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced May 21, 2026, 10:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–12 of 12 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Condition: Vitreomacular Adhesion Clear all
Completed Phase 2 Interventional Results available
View directory record Official record
Conditions
Symptomatic Focal Vitreomacular Adhesion
Interventions
2.0mg of ALG-1001, Balanced Salt Solution
Drug
Lead sponsor
Allegro Ophthalmics, LLC
Industry
Eligibility
18 Years and older
Enrollment
45 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014 – 2015
U.S. locations
5
States / cities
Beverly Hills, California • Santa Barbara, California • Winter Haven, Florida + 2 more
Source: ClinicalTrials.gov public record
Updated Dec 18, 2018 · Synced May 21, 2026, 10:56 PM EDT
Withdrawn Not applicable Interventional
View directory record Official record
Conditions
Vitreomacular Adhesion
Interventions
Intravitreal Injection of sulfahexafluoride gas
Procedure
Lead sponsor
Northern California Retina Vitreous Associates
Other
Eligibility
18 Years and older
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2015
U.S. locations
1
States / cities
Mountain View, California
Source: ClinicalTrials.gov public record
Updated Feb 1, 2016 · Synced May 21, 2026, 10:56 PM EDT
Completed No phase listed Observational
View directory record Official record
Conditions
Symptomatic Vitreomacular Adhesion (VMA)
Interventions
Not listed
Lead sponsor
ThromboGenics
Industry
Eligibility
18 Years and older
Enrollment
134 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014 – 2015
U.S. locations
24
States / cities
Campbell, California • La Jolla, California • Santa Ana, California + 20 more
Source: ClinicalTrials.gov public record
Updated Jul 8, 2015 · Synced May 21, 2026, 10:56 PM EDT
Completed No phase listed Observational
View directory record Official record
Conditions
Symptomatic Vitreomacular Adhesion
Interventions
Not listed
Lead sponsor
ThromboGenics
Industry
Eligibility
18 Years and older
Enrollment
540 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014 – 2016
U.S. locations
110
States / cities
Phoenix, Arizona • Beverly Hills, California • Encino, California + 92 more
Source: ClinicalTrials.gov public record
Updated Jun 20, 2016 · Synced May 21, 2026, 10:56 PM EDT
Completed Phase 3 Interventional Results available
View directory record Official record
Conditions
Vitreomacular Adhesion
Interventions
125 µg Ocriplasmin, Placebo
Drug
Lead sponsor
ThromboGenics
Industry
Eligibility
18 Years and older
Enrollment
326 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2010
U.S. locations
41
States / cities
Phoenix, Arizona • Tucson, Arizona • Beverly Hills, California + 35 more
Source: ClinicalTrials.gov public record
Updated Dec 16, 2014 · Synced May 21, 2026, 10:56 PM EDT
Completed Phase 3 Interventional Results available
View directory record Official record
Conditions
Vitreomacular Adhesion Including Macular Hole
Interventions
Ocriplasmin, Sham injection
Drug · Other
Lead sponsor
ThromboGenics
Industry
Eligibility
18 Years and older
Enrollment
220 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2014
U.S. locations
25
States / cities
Phoenix, Arizona • Beverly Hills, California • Sacramento, California + 22 more
Source: ClinicalTrials.gov public record
Updated Mar 13, 2016 · Synced May 21, 2026, 10:56 PM EDT
Completed Phase 2 Interventional Results available
View directory record Official record
Conditions
Exudative Age-Related Macular Degeneration, Focal Vitreomacular Adhesion
Interventions
Ocriplasmin, Sham injection
Drug
Lead sponsor
ThromboGenics
Industry
Eligibility
50 Years and older
Enrollment
100 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010 – 2013
U.S. locations
12
States / cities
Beverly Hills, California • Sacramento, California • Aurora, Colorado + 9 more
Source: ClinicalTrials.gov public record
Updated Dec 16, 2014 · Synced May 21, 2026, 10:56 PM EDT
Completed No phase listed Observational Accepts healthy volunteers
View directory record Official record
Conditions
Vitreomacular Adhesion
Interventions
Not listed
Lead sponsor
Nova Southeastern University
Other
Eligibility
40 Years and older
Enrollment
1,584 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014 – 2017
U.S. locations
18
States / cities
Birmingham, Alabama • Scottsdale, Arizona • Sepulveda, California + 13 more
Source: ClinicalTrials.gov public record
Updated Mar 28, 2018 · Synced May 21, 2026, 10:56 PM EDT
Completed No phase listed Observational
View directory record Official record
Conditions
Symptomatic Vitreomacular Adhesion
Interventions
ocriplasmin, placebo
Drug
Lead sponsor
ThromboGenics
Industry
Eligibility
18 Years and older
Enrollment
24 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011
U.S. locations
1
States / cities
Houston, Texas
Source: ClinicalTrials.gov public record
Updated Jan 12, 2017 · Synced May 21, 2026, 10:56 PM EDT
Not listed Phase 2 Interventional
View directory record Official record
Conditions
Macular Degeneration
Interventions
Microplasmin, Placebo control
Drug
Lead sponsor
University of California, Los Angeles
Other
Eligibility
50 Years and older
Enrollment
30 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2011
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Sep 26, 2011 · Synced May 21, 2026, 10:56 PM EDT
Completed Phase 3 Interventional Results available
View directory record Official record
Conditions
Vitreomacular Adhesion
Interventions
Ocriplasmin 125µg, Placebo
Drug
Lead sponsor
ThromboGenics
Industry
Eligibility
18 Years and older
Enrollment
326 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2010
U.S. locations
20
States / cities
Campbell, California • San Francisco, California • Santa Barbara, California + 17 more
Source: ClinicalTrials.gov public record
Updated Dec 16, 2014 · Synced May 21, 2026, 10:56 PM EDT
Completed Phase 1 Interventional
View directory record Official record
Conditions
Vitreomacular Attachment, Vitreomacular Traction, Vitreomacular Adhesion
Interventions
36% Resolvine Intravitreal Injection, 9% Resolvine Intravitreal Injection
Drug
Lead sponsor
Jeffrey S Heier
Other
Eligibility
18 Years and older
Enrollment
21 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2015
U.S. locations
2
States / cities
Beverly Hills, California • Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Mar 30, 2016 · Synced May 21, 2026, 10:56 PM EDT